Sichuan Hebang Biotechnology Co.,Ltd. Fundamental Rankings
This page is comprehensive fundamental data for Sichuan Hebang Biotechnology Co.,Ltd.. Fundamentals are ordered by how Sichuan Hebang Biotechnology Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.
Cite in Wikipedia:
| Indicator | Value | n/price | Rank | Date | Historic |
|---|---|---|---|---|---|
| Goodwill | 1,263,185,062 | 0.08132 | 49 | 2015-06-30 | historic |
| Investment income from associate and joint venture | 23,024,038 | 0.00148 | 124 | 2015-06-30 | historic |
| Construction materials | 11,088,021 | 7.1E-4 | 127 | 2015-06-30 | historic |
| Net change in cash | 753,498,440 | 0.04851 | 166 | 2015-06-30 | historic |
| Intangible assets | 879,195,215 | 0.0566 | 184 | 2015-06-30 | historic |
| Special reserve | 8,176,604 | 5.3E-4 | 196 | 2015-06-30 | historic |
| Capital reserve | 3,266,306,729 | 0.21026 | 220 | 2015-06-30 | historic |
| Cash inflows from financing activities | 3,244,186,696 | 0.20884 | 254 | 2015-06-30 | historic |
| Net cashflow from financing activities | 829,169,991 | 0.05338 | 257 | 2015-06-30 | historic |
| Total non-current assets | 7,594,952,701 | 0.48891 | 258 | 2015-06-30 | historic |
| Cash paid for other financing activities | 67,092,985 | 0.00432 | 273 | 2015-06-30 | historic |
| Interests payable | 22,397,470 | 0.00144 | 282 | 2015-06-30 | historic |
| Purchases of fixed assets and others | 267,314,503 | 0.01721 | 321 | 2015-06-30 | historic |
| Short term borrowings | 1,768,000,000 | 0.11381 | 327 | 2015-06-30 | historic |
| Fixed assets | 2,909,996,716 | 0.18733 | 330 | 2015-06-30 | historic |
| Financial expenses | 71,773,971 | 0.00462 | 350 | 2015-06-30 | historic |
| Long term equity investment | 162,905,569 | 0.01049 | 393 | 2015-06-30 | historic |
| Cash paid for dividends, profits or interests | 175,923,720 | 0.01132 | 411 | 2015-06-30 | historic |
| Total liabilities and equity | 10,306,468,830 | 0.66346 | 482 | 2015-06-30 | historic |
| Long term borrowings | 170,000,000 | 0.01094 | 517 | 2015-06-30 | historic |
| Deferred tax assets | 43,902,172 | 0.00283 | 525 | 2015-06-30 | historic |
| Accounts payable | 726,626,740 | 0.04678 | 527 | 2015-06-30 | historic |
| Total liabilities | 4,118,756,381 | 0.26514 | 527 | 2015-06-30 | historic |
| Prepayment | 165,107,978 | 0.01063 | 539 | 2015-06-30 | historic |
| Operating profit | 160,308,394 | 0.01032 | 583 | 2015-06-30 | historic |
| Inventories | 931,674,272 | 0.05997 | 590 | 2015-06-30 | historic |
| Other current assets | 76,699,812 | 0.00494 | 595 | 2015-06-30 | historic |
| Net income | 136,650,404 | 0.0088 | 613 | 2015-06-30 | historic |
| Total comprehensive income | 136,650,404 | 0.0088 | 624 | 2015-06-30 | historic |
| Total profit | 160,793,267 | 0.01035 | 628 | 2015-06-30 | historic |
| Net cash and cash equivalents ending balance | 892,976,350 | 0.05748 | 644 | 2015-06-30 | historic |
| Notes receivable | 35,262,703 | 0.00227 | 717 | 2015-06-30 | historic |
| Selling expenses | 59,399,172 | 0.00382 | 734 | 2015-06-30 | historic |
| Payroll payable | 24,959,850 | 0.00161 | 761 | 2015-06-30 | historic |
| Total cost of goods sold | 1,225,736,912 | 0.0789 | 770 | 2015-06-30 | historic |
| Revenue | 1,358,478,150 | 0.08745 | 775 | 2015-06-30 | historic |
| Diluted eps | 0 | 0.0 | 779 | 2015-06-30 | historic |
| Other payables | 74,979,505 | 0.00483 | 823 | 2015-06-30 | historic |
| Net cash flows from investing activities | -262,766,919 | -0.01692 | 843 | 2015-06-30 | historic |
| Cash inflows from operating activities | 1,195,804,265 | 0.07698 | 853 | 2015-06-30 | historic |
| Disposal of fixed assets and others | 4,466 | 0.0 | 915 | 2015-06-30 | historic |
| Cash outflows from operating activities | 1,010,232,171 | 0.06503 | 922 | 2015-06-30 | historic |
| Non-operating loss | 156,127 | 1.0E-5 | 1119 | 2015-06-30 | historic |
| Cash paid for taxes | 43,787,888 | 0.00282 | 1121 | 2015-06-30 | historic |
| Other receivables | 2,195,567 | 1.4E-4 | 1313 | 2015-06-30 | historic |